An observational study in Health Problems in Pregnancy, Pregnancy Outcomes and Gestational Diabetes, sponsored by Peking University. Recruiting at 1 site in China. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-11-24.
Sponsored by Peking University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 68 studies in Diabetes, Gestational with a site in China — 19 open to participants now, 23 under way, none of them phase 3. Diabetes, Gestational · China.
Among the 68 studies in Diabetes, Gestational with a site in China, this one is the 12th largest by planned enrollment of the 29 observational ones that give a count, is one of 5 that started in 2024, is one of 29 observational ones, reaches primary completion later than 15 of the 22 other live ones, and was the 55th registered.
878 studies on the registry are indexed under Diabetes, Gestational; 196 are open to participants now.
Browse Diabetes, Gestational studies →19 of the 68 studies in Diabetes, Gestational with a site in China are open now. Recruiting first, the newest first:
Yang ZHANG · Sites in China
Ages 18+ · Women only
Fudan University · Sites in China
Ages 18–40 · Women only · Healthy volunteers
Women's Hospital School Of Medicine Zhejiang University · Sites in China
Ages 18–50 · Women only
Peking Union Medical College Hospital · Sites in China
Ages 18+ · Women only
Peking Union Medical College Hospital · Sites in China
Ages 20–45 · Women only
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 132 Diabetes, Gestational studies recruiting now, 60 (45%) set no upper age limit and 70 (53%) stop at 75 or younger; 12 take children under 18; 60 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
68 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 5 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 2,800 is above the median of 175 across 290 observational studies indexed under Diabetes, Gestational.
Median enrollment 291 across the 39 interventional studies, 1,122 across the 29 observational. Of the 17 that completed or were terminated, 2 (12%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 68 has an industry lead sponsor. The 10 most frequent:
Peking University is the lead sponsor of 420 studies on the registry; 124 are open to participants now.
Peking University has 4 studies filed under Diabetes, Gestational — fewer than ten, so there is no comparison to draw.
2 of the studies in Diabetes, Gestational with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06234332Peking UniversityPeking University Birth Cohort in Weifang (PKUBC-WF) | 2026-12-31 |
| NCT07119177Yang ZHANGLong-term Evaluation of Gestational Endocrine & Metabolic Dynamics | 2026-12-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 68 studies in Diabetes, Gestational with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The PKUBC-WF is a prospective cohort study carried out in Weifang city of Shandong, China. The primary aim of this study is to investigate the short-term and long-term effects of pre-pregnant and prenatal exposure on maternal and child health. Data are collected regarding environmental, nutritional and lifestyle exposures as well as short-term and long-term health outcomes of mothers and their children from birth to before 18 years old. Biological samples including peripheral blood, urine, placenta, umbilical cord, cord blood, and faeces are also collected.
Maternal and child health is of great concern globally. Early life phase of a fetus and infant is a critical period for the development of health and disease in the whole life. Exposure of negative environmental, nutritional and lifestyle factors in pregnant women during this period can have adverse effects on fetal and infant. In addition, for mothers, complications during pregnancy could also have a negative effect on long-term health of mothers, such as diabetes, hypertension. Thus, the Peking University Birth Cohort in Weifang is primarily aimed to investigate the short-term and long-term effects of pre-pregnant and prenatal exposure on maternal and child health. Data are collected regarding environmental, nutritional and lifestyle exposures as well as short-term and long-term health outcomes of mothers, husbands and their children from birth to before 18 years old. Biological samples including peripheral blood, urine, placenta, umbilical cord, cord blood, and faeces samples are also collected.
Pregnant women and their children in Weifang, China
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Pregnant woman
Pregnant woman's husband
Offspring 4. Children born to pregnant women who met the inclusion criteria after enrolling in this study.
5. Before the age of 8 years, his/her mother provided written informed consent. 6. After 8 years old, he/she agreed to continue this study and signed the informed consent.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Group with environmental, nutritional or lifestyle exposures
Other: No Interventions
Group without any environmental, nutritional and lifestyle exposures
No intervention This is an observational study without any intervention
Numbers and morbidity of participants with pregnancy complications
Including gestational diabetes, gestational hypertension, anemia, and hypothyroidism during pregnancy
Time frame: At delivery
Numbers and morbidity of participants with adverse pregnancy outcomes
Including preterm birth, low birth weight, macrosomia, abortion, stillbirth, and birth defects.
Time frame: At delivery
Weight in kilogram changes during childhood
Measured by health professionals in clinic
Time frame: At birth and age at 6 weeks, 6 months, 12 months, 2 years, 3 years, 6 years, 9 years, 12 years, 15 years, and 17 years
Height in centimeter changes during childhood
Measured by health professionals in clinic
Time frame: At birth and age at 6 weeks, 6 months, 12 months, 2 years, 3 years, 6 years, 9 years, 12 years, 15 years, and 17 years
Early Child development
Measured by Ages\&Stages Questionnaires (ASQ).There are 6 questions in each of 5 domains of development: communication, gross motor, fine motor, problem-solving skills, and adaptive skills. Each question is given a 10 (yes), 5 (sometimes), or 0 (not yet) score according to the parents' answers. The sum scores (range from 0 to 300) and scores for each domain (range from 0 to 60) are calculated. Chinese norms are available for each domain, and any domain screened \<2 SDs below the mean is considered a positive screening. A higher ASQ score means better development.
Time frame: Age at 6 weeks, 6 months and 12 months
Incidence of diabetes mellitus in women
Measured by health professionals in clinic
Time frame: 6 weeks after delivery and 3 years after delivery
Incidence of hypertension in women
Measured by health professionals in clinic
Time frame: 6 weeks after delivery and 3 years after delivery
Incidence of child overweight and obesity
Measured by health professionals in clinic
Time frame: At birth and age at 6 weeks, 6 months, 12 months, 2 years, 3 years, 6 years, 9 years, 12 years, 15 years, and 17 years
Incidence of autism spectrum disorder in children
Measured by The Modified Checklist for Autism in Toddlers, Revised with Follow-Up (M-CHAT-R/F) and Autism Behavior Checklist (ABC) scales
Time frame: Age at 2 years, 3 years
Incidence of attention-deficit/hyperactivity disorder in children
Measured by The Child Behavior Checklist (CBC) scale
Time frame: Age at 6 years
Incidence of anxiety in adolescents
Measured by Social Anxiety Scale for Adolescents (SAS-A) scale
Time frame: Age at 9 years, 12 years, 15 years, and 17 years
Incidence of depression in adolescents
Measured by Beck Depression Inventory-II (BDI-II) scale
Time frame: Age at 9 years, 12 years, 15 years, and 17 years
Plan to share: No
No publications or documents are linked to this record.
Started Feb 2024 (actual). Primary completion is estimated for Dec 2026, 34 months after the start.
Of 142 non-industry observational studies under Diabetes, Gestational, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 70. This study's planned 34 months is below that.
Counting every sponsor, half of 144 studies reached it within 43 months; a quarter within 19 and three quarters within 73.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.